Global Measles, Mumps, and Rubella Virus Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles).
Measles, Mumps, and Rubella Virus Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Measles, Mumps, and Rubella Virus Vaccine market is projected to reach US$ 506.6 million in 2029, increasing from US$ 388 million in 2022, with the CAGR of 3.8% during the period of 2024 to 2029. Demand from Public and Private are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Measles, Mumps, and Rubella Virus Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck
Minhai Bio
Shanghai Institute of Biological
Beijing Institute of Biological
Segment by Type
Child
Adult
Segment by Application
Public
Private
Segment by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Measles, Mumps, and Rubella Virus Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Measles, Mumps, and Rubella Virus Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Measles, Mumps, and Rubella Virus Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Measles, Mumps, and Rubella Virus Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Measles, Mumps, and Rubella Virus Vaccine introduction, etc. Measles, Mumps, and Rubella Virus Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Measles, Mumps, and Rubella Virus Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Table of Content
1 Measles, Mumps, and Rubella Virus Vaccine Market Overview
1.1 Measles, Mumps, and Rubella Virus Vaccine Product Overview
1.2 Measles, Mumps, and Rubella Virus Vaccine Market Segment by Type
1.2.1 Child
1.2.2 Adult
1.3 Global Measles, Mumps, and Rubella Virus Vaccine Market Size by Type
1.3.1 Global Measles, Mumps, and Rubella Virus Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Measles, Mumps, and Rubella Virus Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Measles, Mumps, and Rubella Virus Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Measles, Mumps, and Rubella Virus Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Measles, Mumps, and Rubella Virus Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Measles, Mumps, and Rubella Virus Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales Breakdown by Type (2018-2024)
2 Global Measles, Mumps, and Rubella Virus Vaccine Market Competition by Company
2.1 Global Top Players by Measles, Mumps, and Rubella Virus Vaccine Sales (2018-2024)
2.2 Global Top Players by Measles, Mumps, and Rubella Virus Vaccine Revenue (2018-2024)
2.3 Global Top Players by Measles, Mumps, and Rubella Virus Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Measles, Mumps, and Rubella Virus Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Measles, Mumps, and Rubella Virus Vaccine Market Competitive Situation and Trends
2.5.1 Measles, Mumps, and Rubella Virus Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Measles, Mumps, and Rubella Virus Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Measles, Mumps, and Rubella Virus Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Measles, Mumps, and Rubella Virus Vaccine Market
2.8 Key Manufacturers Measles, Mumps, and Rubella Virus Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Measles, Mumps, and Rubella Virus Vaccine Status and Outlook by Region
3.1 Global Measles, Mumps, and Rubella Virus Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Measles, Mumps, and Rubella Virus Vaccine Historic Market Size by Region
3.2.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Measles, Mumps, and Rubella Virus Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Measles, Mumps, and Rubella Virus Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Measles, Mumps, and Rubella Virus Vaccine Forecasted Market Size by Region
3.3.1 Global Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Measles, Mumps, and Rubella Virus Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Measles, Mumps, and Rubella Virus Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Measles, Mumps, and Rubella Virus Vaccine by Application
4.1 Measles, Mumps, and Rubella Virus Vaccine Market Segment by Application
4.1.1 Public
4.1.2 Private
4.2 Global Measles, Mumps, and Rubella Virus Vaccine Market Size by Application
4.2.1 Global Measles, Mumps, and Rubella Virus Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Measles, Mumps, and Rubella Virus Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Measles, Mumps, and Rubella Virus Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Measles, Mumps, and Rubella Virus Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Measles, Mumps, and Rubella Virus Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Measles, Mumps, and Rubella Virus Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales Breakdown by Application (2018-2024)
5 North America Measles, Mumps, and Rubella Virus Vaccine by Country
5.1 North America Measles, Mumps, and Rubella Virus Vaccine Historic Market Size by Country
5.1.1 North America Measles, Mumps, and Rubella Virus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Measles, Mumps, and Rubella Virus Vaccine Sales in Value by Country (2018-2024)
5.2 North America Measles, Mumps, and Rubella Virus Vaccine Forecasted Market Size by Country
5.2.1 North America Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Measles, Mumps, and Rubella Virus Vaccine Sales in Value by Country (2024-2029)
6 Europe Measles, Mumps, and Rubella Virus Vaccine by Country
6.1 Europe Measles, Mumps, and Rubella Virus Vaccine Historic Market Size by Country
6.1.1 Europe Measles, Mumps, and Rubella Virus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Measles, Mumps, and Rubella Virus Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Measles, Mumps, and Rubella Virus Vaccine Forecasted Market Size by Country
6.2.1 Europe Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Measles, Mumps, and Rubella Virus Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine by Region
7.1 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales in Value by Region (2024-2029)
8 Latin America Measles, Mumps, and Rubella Virus Vaccine by Country
8.1 Latin America Measles, Mumps, and Rubella Virus Vaccine Historic Market Size by Country
8.1.1 Latin America Measles, Mumps, and Rubella Virus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Measles, Mumps, and Rubella Virus Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Measles, Mumps, and Rubella Virus Vaccine Forecasted Market Size by Country
8.2.1 Latin America Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Measles, Mumps, and Rubella Virus Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine by Country
9.1 Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Measles, Mumps, and Rubella Virus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck Measles, Mumps, and Rubella Virus Vaccine Products Offered
10.1.5 Merck Recent Development
10.2 Minhai Bio
10.2.1 Minhai Bio Company Information
10.2.2 Minhai Bio Introduction and Business Overview
10.2.3 Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Products Offered
10.2.5 Minhai Bio Recent Development
10.3 Shanghai Institute of Biological
10.3.1 Shanghai Institute of Biological Company Information
10.3.2 Shanghai Institute of Biological Introduction and Business Overview
10.3.3 Shanghai Institute of Biological Measles, Mumps, and Rubella Virus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Shanghai Institute of Biological Measles, Mumps, and Rubella Virus Vaccine Products Offered
10.3.5 Shanghai Institute of Biological Recent Development
10.4 Beijing Institute of Biological
10.4.1 Beijing Institute of Biological Company Information
10.4.2 Beijing Institute of Biological Introduction and Business Overview
10.4.3 Beijing Institute of Biological Measles, Mumps, and Rubella Virus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Beijing Institute of Biological Measles, Mumps, and Rubella Virus Vaccine Products Offered
10.4.5 Beijing Institute of Biological Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Measles, Mumps, and Rubella Virus Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Measles, Mumps, and Rubella Virus Vaccine Industrial Chain Analysis
11.4 Measles, Mumps, and Rubella Virus Vaccine Market Dynamics
11.4.1 Measles, Mumps, and Rubella Virus Vaccine Industry Trends
11.4.2 Measles, Mumps, and Rubella Virus Vaccine Market Drivers
11.4.3 Measles, Mumps, and Rubella Virus Vaccine Market Challenges
11.4.4 Measles, Mumps, and Rubella Virus Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Measles, Mumps, and Rubella Virus Vaccine Distributors
12.3 Measles, Mumps, and Rubella Virus Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Figure
List of Tables
Table 1. Major Company of Child
Table 2. Major Company of Adult
Table 3. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2018-2024) & (K Units)
Table 5. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2018-2024) & (US& Million)
Table 7. Global Measles, Mumps, and Rubella Virus Vaccine Market Share in Value by Type (2018-2024)
Table 8. Global Measles, Mumps, and Rubella Virus Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2024-2029) & (K Units)
Table 10. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Type (2024-2029)
Table 13. Global Measles, Mumps, and Rubella Virus Vaccine Price by Type (2024-2029) & (USD/Unit)
Table 14. North America Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2018-2024) & (K Units)
Table 15. North America Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Measles, Mumps, and Rubella Virus Vaccine Sales (K Units) by Type (2018-2024)
Table 17. Europe Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Measles, Mumps, and Rubella Virus Vaccine Sales (K Units) by Type (2018-2024)
Table 21. Latin America Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Company (2018-2024) & (K Units)
Table 25. Global Measles, Mumps, and Rubella Virus Vaccine Sales Share by Company (2018-2024)
Table 26. Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Measles, Mumps, and Rubella Virus Vaccine Revenue Share by Company (2018-2024)
Table 28. Global Market Measles, Mumps, and Rubella Virus Vaccine Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Measles, Mumps, and Rubella Virus Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Measles, Mumps, and Rubella Virus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Measles, Mumps, and Rubella Virus Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Measles, Mumps, and Rubella Virus Vaccine Market
Table 33. Key Manufacturers Measles, Mumps, and Rubella Virus Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Measles, Mumps, and Rubella Virus Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Region (2018-2024)
Table 40. Global Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Region (2024-2029) & (K Units)
Table 42. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Region (2024-2029)
Table 45. Global Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 46. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2018-2024) & (K Units)
Table 48. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Application (2018-2024)
Table 51. Global Measles, Mumps, and Rubella Virus Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Application (2024-2029)
Table 56. Global Measles, Mumps, and Rubella Virus Vaccine Price by Application (2024-2029) & (USD/Unit)
Table 57. North America Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2018-2024) (K Units)
Table 58. North America Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2018-2024) (K Units)
Table 60. Europe Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2018-2024) (K Units)
Table 64. Latin America Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2018-2024) & (K Units)
Table 68. North America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Country (2018-2024)
Table 71. North America Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2024-2029) & (K Units)
Table 72. North America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2018-2024) & (K Units)
Table 76. Europe Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2024-2029) & (K Units)
Table 80. Europe Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Country (2024-2029)
Table 107. Merck Company Information
Table 108. Merck Introduction and Business Overview
Table 109. Merck Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Merck Measles, Mumps, and Rubella Virus Vaccine Product
Table 111. Merck Recent Development
Table 112. Minhai Bio Company Information
Table 113. Minhai Bio Introduction and Business Overview
Table 114. Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Product
Table 116. Minhai Bio Recent Development
Table 117. Shanghai Institute of Biological Company Information
Table 118. Shanghai Institute of Biological Introduction and Business Overview
Table 119. Shanghai Institute of Biological Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Shanghai Institute of Biological Measles, Mumps, and Rubella Virus Vaccine Product
Table 121. Shanghai Institute of Biological Recent Development
Table 122. Beijing Institute of Biological Company Information
Table 123. Beijing Institute of Biological Introduction and Business Overview
Table 124. Beijing Institute of Biological Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Beijing Institute of Biological Measles, Mumps, and Rubella Virus Vaccine Product
Table 126. Beijing Institute of Biological Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Measles, Mumps, and Rubella Virus Vaccine Market Trends
Table 130. Measles, Mumps, and Rubella Virus Vaccine Market Drivers
Table 131. Measles, Mumps, and Rubella Virus Vaccine Market Challenges
Table 132. Measles, Mumps, and Rubella Virus Vaccine Market Restraints
Table 133. Measles, Mumps, and Rubella Virus Vaccine Distributors List
Table 134. Measles, Mumps, and Rubella Virus Vaccine Downstream Customers
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Measles, Mumps, and Rubella Virus Vaccine Product Picture
Figure 2. Global Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Measles, Mumps, and Rubella Virus Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Measles, Mumps, and Rubella Virus Vaccine Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Child
Figure 6. Global Child Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Adult
Figure 8. Global Adult Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Type in 2022 & 2029
Figure 11. North America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Measles, Mumps, and Rubella Virus Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Measles, Mumps, and Rubella Virus Vaccine Revenue in 2022
Figure 23. Measles, Mumps, and Rubella Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Public
Figure 25. Global Public Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Private
Figure 27. Global Private Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share by Application in 2022 & 2029
Figure 30. North America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Application in 2022
Figure 31. North America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Application in 2022
Figure 32. Europe Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. Europe Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Latin America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Measles, Mumps, and Rubella Virus Vaccine Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Measles, Mumps, and Rubella Virus Vaccine Manufacturing Cost Structure
Figure 41. Measles, Mumps, and Rubella Virus Vaccine Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices